Bladder Wall Perfusion Pattern and Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms, and the Association of That Perfusion Pattern and Therapeutic Efficacy of Antimuscarinics for Female Overactive Bladder Syndrome.
Phase of Trial: Phase III
Latest Information Update: 20 Sep 2016
At a glance
- Drugs Tolterodine (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 04 Sep 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 04 Sep 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Jul 2017.
- 06 Jul 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2016 as per ClinicalTrials.gov record.